Variant report

Variant	rs9492894
Chromosome Location	chr6:131615143-131615144
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:131591823..131594173-chr6:131613820..131615536,2	K562	blood:
2	chr6:131614360..131616508-chr6:131705803..131707677,2	K562	blood:

Extended variants
information (count: 12 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:7)

rs_ID	r²[population]
rs12203075	0.82[AMR][1000 genomes];0.83[ASN][1000 genomes]
rs1407532	0.84[ASN][1000 genomes]
rs1407533	0.82[AMR][1000 genomes];0.84[ASN][1000 genomes]
rs4327722	0.83[ASN][1000 genomes]
rs4343939	0.81[ASN][1000 genomes]
rs9483244	0.85[AMR][1000 genomes];0.85[ASN][1000 genomes]
rs9483245	0.82[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1032955	chr6:131298803-131818502	Active TSS Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
2	nsv538443	chr6:131298803-131818502	Active TSS Weak transcription ZNF genes & repeats Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
3	nsv886664	chr6:131443843-131754930	Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
4	nsv830808	chr6:131521115-131735320	Enhancers Flanking Active TSS Active TSS Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1 gene(s)	inside rSNPs	diseases
5	nsv886666	chr6:131573433-131666295	Weak transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region lncRNA miRNA target site	1 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:30 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:131612200-131615600	Enhancers	iPS-20b Cell Line	embryonic stem cell
2	chr6:131612400-131616400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr6:131612600-131615400	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr6:131612800-131615600	Enhancers	HUES64 Cell Line	embryonic stem cell
5	chr6:131612800-131616600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr6:131613000-131615600	Enhancers	H1 Cell Line	embryonic stem cell
7	chr6:131613000-131615600	Enhancers	iPS-18 Cell Line	embryonic stem cell
8	chr6:131613000-131615600	Enhancers	Fetal Intestine Large	intestine
9	chr6:131613000-131615800	Enhancers	Fetal Intestine Small	intestine
10	chr6:131613000-131616400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr6:131614200-131616000	Enhancers	Stomach Mucosa	stomach
12	chr6:131614400-131615800	Enhancers	Gastric	stomach
13	chr6:131614800-131616200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr6:131614800-131616400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr6:131614800-131619000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
16	chr6:131614800-131620000	Weak transcription	Spleen	Spleen
17	chr6:131614800-131624800	Weak transcription	Primary T helper cells PMA-I stimulated	--
18	chr6:131615000-131615200	Active TSS	HUES6 Cell Line	embryonic stem cell
19	chr6:131615000-131615400	Weak transcription	H9 Cell Line	embryonic stem cell
20	chr6:131615000-131615400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr6:131615000-131615400	Bivalent/Poised TSS	HepG2	liver
22	chr6:131615000-131615600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr6:131615000-131616200	Weak transcription	Pancreas	Pancrea
24	chr6:131615000-131616400	Active TSS	ES-WA7 Cell Line	embryonic stem cell
25	chr6:131615000-131617000	Active TSS	ES-I3 Cell Line	embryonic stem cell
26	chr6:131615000-131620600	Active TSS	iPS-15b Cell Line	embryonic stem cell
27	chr6:131615000-131622400	Weak transcription	Lung	lung
28	chr6:131615000-131623800	Weak transcription	Primary T cells from cord blood	blood
29	chr6:131615000-131624400	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
30	chr6:131615000-131626200	Weak transcription	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links